Targeson Inc.

Targeson develops, manufactures, and markets microsphere- (or microbubble-) based products specifically for preclinical research and early-stage drug development. The company has engineered a versatile microsphere platform that is used for various ultrasound contrast agents, drug or gene delivery agents, and for targeted cell separation applications.

UVA Founders: Dr. Klaus Ley, Joshua Rychak

Contact:

3550 General Atomics Ct. 
MS 02 - 444
San Diego, CA 92121

http://targeson.com/

targeson.com/